Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

2-phosphoglycerate kinase

Example Change in Dynamics on Denaturing Phosphoglycerate Kinase... [Pg.248]

Figure 6 Apparent elastic incoherent structure factor A q(Q) for ( ) denatured and ( ) native phosphoglycerate kinase. The solid line represents the fit of a theoretical model in which a fraction of the hydrogens of the protein execute only vihrational motion (this fraction is given by the dotted line) and the rest undergo diffusion in a sphere. For more details see Ref. 25. Figure 6 Apparent elastic incoherent structure factor A q(Q) for ( ) denatured and ( ) native phosphoglycerate kinase. The solid line represents the fit of a theoretical model in which a fraction of the hydrogens of the protein execute only vihrational motion (this fraction is given by the dotted line) and the rest undergo diffusion in a sphere. For more details see Ref. 25.
FIGURE 6.28 Examples of protein domains with different numbers of layers of backbone strnctnre. (a) Cytochrome c with two layers of a-helix. (b) Domain 2 of phosphoglycerate kinase, composed of a /3-sheet layer between two layers of helix, three layers overall, (c) An nnnsnal five-layer strnctnre, domain 2 of glycogen phosphorylase, a /S-sheet layer sandwiched between four layers of a-helix. (d) The concentric layers of /S-sheet (inside) and a-helix (outside) in triose phosphate isomerase. Hydrophobic residnes are bnried between these concentric layers in the same manner as in the planar layers of the other proteins. The hydrophobic layers are shaded yellow. (Jane Richarelson)... [Pg.185]

Glycolysis Glyceraldehyde-3-phosphate dehydrogenase Phosphoglycerate kinase Pyruvate kinase... [Pg.143]

Fig. 3. Three-dimensional model of human phosphoglycerate kinase based on the structure of horse enzyme. Positions of the molecular abnormalities of variant enzymes are also shown. Fig. 3. Three-dimensional model of human phosphoglycerate kinase based on the structure of horse enzyme. Positions of the molecular abnormalities of variant enzymes are also shown.
Hereditary deficiency of phosphoglycerate kinase (PGK) is associated with hereditary hemolytic anemia and often with central nervous system dysfunction and/or myopathy. The first case, reported by Kraus et al. (K24), is a heterozygous female, and the results are not so clear. The second family, reported by Valentine et al. (V3), is a large Chinese family, whose pedigree study indicates that PGK deficiency is compatible with X-linked inheritance. To date, 22 families have been reported (04, T25, Y3). Nine of these have manifested both symptoms five have shown only hemolysis seven have shown the central nervous system dysfunction and/or myopathy but without hemolysis and one case, PGK Munchen, is without clinical symptoms (F5). PGK II is an electrophoretic variant found in New Guinea populations (Y2). Red blood cell enzyme activity, specific activity, and the kinetic properties of this polymorphic variant are normal. [Pg.21]

Cl2. Cohen-Solal, M., Valentin, C., Plassa, F., Guillemin, G Danze, F., Jaisson, F., and Rosa, R., Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes PGK Crdteil and PGK Amiens. Blood 84,898-903 (1994). [Pg.40]

F5. Fujii, H., Krietsch, W. K. G., and Yoshida, A., A single amino acid substitution (Asp -> Asn) in a phosphoglycerate kinase variant (PGK Miinchen) associated with enzyme deficiency. J. Biol. Chem. 255,6421-6423 (1980). [Pg.41]

F8. Fujii, H., Chen, S.-H., Akatsuka, J Miwa, S., and Yoshida, A., Use of cultured lymphoblastoid cells for the study of abnormal enzymes Molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemia. Proc. Natl. Acad. Sci. U.S.A. 78,2587-2590 (1981). [Pg.41]

M2. Maeda, M and Yoshida, A., Molecular defect of a phosphoglycerate kinase variant (PGK-Mat-sue) associated with hemolytic anemia Leu - Pro substitution caused by T/A - C/G transition in exon 3. Blood 77, 1348-1352(1991). [Pg.45]

M3. Maeda, M., Bawle, E. V., Kulkami, R Beutler, E., and Yoshida, A., Molecular abnormality of a phosphoglycerate kinase variant generated by spontaneous mutation. Blood 79,2759-2762 (1992). [Pg.45]

Ookawara, T., Dave, V., Willems, P Martin, J.-J., de Barsy, T., Matthys, E., and Yoshida, A., Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant. Arch. Biochem. Biophys. 327, 35-40 (1996). [Pg.48]

T21. Tougard, P., Le, T. H., Minard, P Desmadril, M., Yon, J. M., Bizebard, T., Lebras, G and Dumas, C., Structural and functional properties of mutant Arg203Pro from yeast phosphoglycerate kinase, as a model of phosphoglycerate kinase-Uppsaia. Protein Eng. 9, 181-187... [Pg.52]

T24. Tsujino, S., Tonin, P Shanske, S., Nohria, V., Boustany, R.-M., Lewis, D Chen, Y.-T., and DiMauro, S., A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina). Ann. Neurol. 35,349-353 (1994). [Pg.52]


See other pages where 2-phosphoglycerate kinase is mentioned: [Pg.248]    [Pg.185]    [Pg.427]    [Pg.614]    [Pg.624]    [Pg.624]    [Pg.624]    [Pg.625]    [Pg.625]    [Pg.626]    [Pg.626]    [Pg.628]    [Pg.630]    [Pg.638]    [Pg.693]    [Pg.733]    [Pg.735]    [Pg.194]    [Pg.302]    [Pg.137]    [Pg.140]    [Pg.1]    [Pg.2]    [Pg.4]    [Pg.9]    [Pg.9]    [Pg.21]    [Pg.37]    [Pg.41]    [Pg.45]   
See also in sourсe #XX -- [ Pg.248 ]

See also in sourсe #XX -- [ Pg.167 ]

See also in sourсe #XX -- [ Pg.131 , Pg.147 , Pg.424 ]

See also in sourсe #XX -- [ Pg.233 , Pg.234 ]

See also in sourсe #XX -- [ Pg.85 ]

See also in sourсe #XX -- [ Pg.654 , Pg.656 ]

See also in sourсe #XX -- [ Pg.23 , Pg.32 , Pg.268 ]

See also in sourсe #XX -- [ Pg.315 ]

See also in sourсe #XX -- [ Pg.821 ]

See also in sourсe #XX -- [ Pg.588 ]

See also in sourсe #XX -- [ Pg.146 ]

See also in sourсe #XX -- [ Pg.41 ]

See also in sourсe #XX -- [ Pg.654 , Pg.656 ]

See also in sourсe #XX -- [ Pg.629 ]

See also in sourсe #XX -- [ Pg.198 ]

See also in sourсe #XX -- [ Pg.443 ]

See also in sourсe #XX -- [ Pg.145 , Pg.157 ]

See also in sourсe #XX -- [ Pg.383 ]

See also in sourсe #XX -- [ Pg.246 , Pg.250 ]

See also in sourсe #XX -- [ Pg.435 ]

See also in sourсe #XX -- [ Pg.302 , Pg.313 ]

See also in sourсe #XX -- [ Pg.162 , Pg.163 ]

See also in sourсe #XX -- [ Pg.643 , Pg.644 ]

See also in sourсe #XX -- [ Pg.654 , Pg.656 ]

See also in sourсe #XX -- [ Pg.643 , Pg.644 ]

See also in sourсe #XX -- [ Pg.654 , Pg.656 ]

See also in sourсe #XX -- [ Pg.507 ]

See also in sourсe #XX -- [ Pg.295 ]

See also in sourсe #XX -- [ Pg.384 ]

See also in sourсe #XX -- [ Pg.197 ]

See also in sourсe #XX -- [ Pg.40 , Pg.42 ]

See also in sourсe #XX -- [ Pg.139 ]

See also in sourсe #XX -- [ Pg.1029 , Pg.1030 ]

See also in sourсe #XX -- [ Pg.45 , Pg.60 , Pg.127 ]

See also in sourсe #XX -- [ Pg.542 ]

See also in sourсe #XX -- [ Pg.171 ]

See also in sourсe #XX -- [ Pg.276 ]

See also in sourсe #XX -- [ Pg.637 ]

See also in sourсe #XX -- [ Pg.62 , Pg.75 , Pg.83 , Pg.97 , Pg.128 , Pg.133 , Pg.250 , Pg.251 , Pg.322 , Pg.323 , Pg.513 ]

See also in sourсe #XX -- [ Pg.962 ]




SEARCH



3-Phosphoglycerate

3-Phosphoglycerate kinase reaction catalyzed

Crystal structure phosphoglycerate kinase

Glycolysis phosphoglycerate kinase

Hereditary hemolytic anemia phosphoglycerate kinase deficiency

Kinases phosphoglycerate kinase

Kinases phosphoglycerate kinase

Muscle phosphoglycerate kinase

Phosphofructokinase Phosphoglycerate kinase

Phosphoglycerate kinase activation

Phosphoglycerate kinase analysis

Phosphoglycerate kinase deficiency

Phosphoglycerate kinase inhibition

Phosphoglycerate kinase, activity

Phosphoglycerate kinase, domains

Phosphoglycerate kinase, function

Phosphoglycerate kinase, nucleotide

Phosphoglycerate kinase, nucleotide binding site

© 2024 chempedia.info